David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,177 shares at $41.35 ($214K) on 2013-10-30, disclosed to the SEC on 2013-10-30.
Scheduled sale ($214k) by Executive VP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.91 | 177 | $7K | 3.4% |
| 2 | $41.35 | 5,000 | $207K | 96.6% |
| Total | $41.33 avg | 5,177 | $214K | 100% |
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |